STAT

OCTOBER 28, 2023

Recently, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. It’s called, appropriately, STAT+ Connect. There, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss news events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and extra material posted by STAT reporters and editors; and watch events, including live in

223

223

Big Molecule Watch

OCTOBER 28, 2023

On October 23, 2023, Celltrion announced FDA approval for ZYMFENTRA (infliximab-dyyb), a subcutaneous formulation for maintenance therapy for patients with moderately to severely active ulcerative colitis and Crohn’s disease. Infliximab is a TNF blocking agent that was first approved by the FDA as an intravenous formulation for the treatment of Crohn’s disease in 1998.

Biosimilars 57

Biosimilars 57

Pharma Marketing Network

OCTOBER 28, 2023

Patient-centricity is a concept that is gaining traction in the pharmaceutical industry. It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. In this article, we will explore the concept of patient-centricity, its impact on digital communication in pharma, the benefits it brings, and the cha

Communication 52

Communication Drug Development 52

EMCrit Project

OCTOBER 28, 2023

All the lit goodness for Oct 2023 EMCrit Project by Scott Weingart, MD FCCM.

79

79

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

RX Note

OCTOBER 28, 2023

Introduction Given the potential for teratogenic effects of certain drugs, this article explores the safe use of over-the-counter medications during pregnancy. Products containing alcohol should be avoided. Pain The use of paracetamol (acetaminophen) in recommended doses during pregnancy has not be associated with an increased risk of miscarriage or still birth.

Community Pharmacies 40

Community Pharmacies 40

GMPSOP

OCTOBER 28, 2023

What are the elements of quality control process in pharmaceuticals Pharmaceuticals quality assurance & validation procedures GMPSOP What are the elements of quality control process in pharmaceuticals Last Updated on October 30, 2023 Prev PREVIOUS POST Table of Contents Why do you need to implement a quality control process if you can manufacture products that are free from all possible contaminants?

Documentation 52

Documentation Method Validation Packaging Data Entry 52